Skip to main content

FDA Revokes Some Methylene Chloride Use, But Decaf Decision Still Pending

decaf coffee

The U.S. Food and Drug Administration (FDA) is revoking several authorizations for methylene chloride in food-related applications, citing evidence that the chemical causes cancer in laboratory animals.

Announced Nov. 9 and scheduled to take effect Jan. 11, 2027, the actions will eliminate methylene chloride’s authorized use in inks for marking fruits and vegetables.

They will also remove approvals for methylene chloride and two other solvents in the manufacture of certain food colorings. Those uses were removed because the FDA determined they had already been abandoned by industry.

Decaf Not Affected

The decision does not address the use of methylene chloride in coffee decaffeination, which remains permitted under existing FDA regulations. However, it comes as the agency is reviewing a separate petition seeking to ban the chemical and other solvents from food processing, including decaf coffee production.

The decision followed petitions submitted by a coalition of consumer and environmental health organizations, including the Environmental Defense Fund (EDF), and by the International Association of Color Manufacturers. EDF is also among the petitioners in the petition still under review. 

In a Nov. 10 statement, EDF welcomed the action but argued that the agency should go further.

“FDA still has not acted on a related petition to remove other uses of these cancer-causing chemicals, including for decaffeinating coffee, even though safer alternatives exist,” Lisa Lefferts, an environmental health consultant and petitioner, said in the announcement. 

The separate food-additive petition, filed in December 2023, seeks to eliminate existing authorizations for benzene, ethylene dichloride, methylene chloride and trichloroethylene.

The petitioners cite the Delaney Clause, a provision of federal law prohibiting the approval of food additives found to cause cancer in humans or animals.

For coffee, methylene chloride is the primary concern. The solvent is used in commercial decaffeination, often described as the European Method. Current FDA regulations permit residues of up to 10 parts per million in decaffeinated roasted coffee and decaffeinated soluble coffee extract.

Mixed Industry Response

Some coffee companies say they have moved away from methylene chloride in decaf sourcing or or emphasized water-process decaffeination. Meanwhile, the National Coffee Association (NCA) has opposed the proposed restrictions, maintaining that European Method decaf is safe under existing federal limits.

In a March 2024 statement, the organization argued that a ban would unnecessarily restrict access to decaf coffee and increase costs. Citing its 2023 National Coffee Data Trends report, the group said about 10% of U.S. adults — roughly 26 million people — drank decaffeinated coffee daily.

The proposed restrictions have also drawn opposition from trade groups including the American Beverage Association and the Consumer Brands Association, according to public comments submitted to the FDA. The FDA’s public petition database lists the petition as under review, with no timetable for a decision.


Comments? Questions? News to share? Contact DCN’s editors here. For all the latest coffee industry news, subscribe to the DCN newsletter.

Comment